CClinicalTrials.gg
CompletedNCT04705961Updated Jan 15, 2021

Bile Leakage Test in Emergency Hydatid Liver Cyst Surgery Case Report

An observational study in Surgery--Complications, sponsored by Dr. Ersin Arslan Education and Training Hospital. Completed at 1 site in Turkey. Open to male participants. Per ClinicalTrials.gov, last updated 2021-01-15.

Sponsored by Dr. Ersin Arslan Education and Training Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
1
Sex
Male
01

Study summary

In liver cyst hydatid surgery, presence of cysto-biliary communication (CBC) is important for the prevention of postoperative morbidity. If cysto-biliary connections are not obvious, diagnosis is not easy. Intraoperative bile leakage test has been shown to reduce postoperative biliary complications by revealing occult CBCs. However, bile leakage testing in emergency conditions such as hydatid cyst perforation has not been experienced so far.

Read the detailed description

In liver cyst hydatid surgery, presence of cysto-biliary communication (CBC) is important for the prevention of postoperative morbidity. If cysto-biliary connections are not obvious, diagnosis is not easy. Intraoperative bile leakage test has been shown to reduce postoperative biliary complications by revealing occult CBCs. However, bile leakage testing in emergency conditions such as hydatid cyst perforation has not been experienced so far.

Here, a bile leakage test performed in a 23-year-old male patient undergoing emergency surgery due to the perforation of the hydatid liver cyst was presented. Following the treatment of perforated hydatid liver cyst and biliary peritonitis, a bile leakage test was performed. The common bile duct was cannulated with a 22 Gauge catheter, normal saline and parenteral lipid solution were given to demonstrate the CBCs, and leakage areas were suture ligated. The patient was discharged postoperatively without any problem.

The investigators recommend detection and treatment of the CBCs even in emergency hydatid liver cyst surgery for prevention of postoperative biliary complications.

02

Conditions studied

  • Surgery--Complications

Browse trials for

Keywords

  • Hydatidosis
  • complications
  • intra-biliary rupture
  • biliary duct
  • echinococcus
  • echinococcosis
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 1 is below the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Dr. Ersin Arslan Education and Training Hospital is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

this study is a case report

Inclusion criteria

  • this study is a case report

Exclusion criteria

Exclusion Criteria:

  • this study is a case report
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
1 participant (actual)
Target follow-up
6 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. recurrent hydatid cyst

    presence of recurrent hydatid cyst

    Time frame: 2 or 3 month

07

Study locations

1 site
  • Dr. Ersin Arslan Training and Resource Hospital
    Gaziantep, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04705961
Lead sponsor
Dr. Ersin Arslan Education and Training Hospital
Responsible party
Ufuk Uylas (Principal Investigator, Dr. Ersin Arslan Education and Training Hospital) — Principal investigator
First posted
Jan 12, 2021
Start date
Jan 1, 2018
Primary completion
Jan 1, 2020
Completion
Jan 10, 2020
Last update
Jan 15, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion